| J9271 | Injection, pembrolizumab, 1 mg | 19,200 | $40 | $806.4K |
| J0897 | Injection, denosumab, 1 mg | 23,040 | $20 | $414.7K |
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 140 | $1,360 | $192.2K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 4,010 | $20 | $88.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 890 | $100 | $88.2K |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 170 | $490 | $83.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 700 | $110 | $76.6K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 130 | $270 | $35.3K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 90 | $320 | $28.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 180 | $140 | $25.5K |